tiprankstipranks
China Regenerative Medicine International Limited (HK:8158)
:8158
Hong Kong Market
8158
China Regenerative Medicine International Limited
RESEARCH TOOLSreports

China Regenerative Medicine International Limited (8158) Ratios

0 Followers

China Regenerative Medicine International Limited Ratios

HK:8158's free cash flow for Q2 2025 was HK$0.65. For the 2025 fiscal year, HK:8158's free cash flow was decreased by HK$ and operating cash flow was HK$-0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.00 0.99 1.14 1.57 1.75
Quick Ratio
 0.98 0.99 1.14 1.57 1.75
Cash Ratio
 0.11 0.39 0.02 0.01 0.07
Solvency Ratio
 0.30 0.26 -0.55 0.06 0.35
Operating Cash Flow Ratio
 -0.08 0.31 0.04 -0.11 -0.02
Short-Term Operating Cash Flow Coverage
 -0.74 5.04 0.47 -0.36 -0.10
Net Current Asset Value
HK$ -39.03MHK$ -52.20MHK$ -5.53MHK$ 77.10MHK$ 110.97M
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.40 0.27 0.26 0.14
Debt-to-Equity Ratio
 1.11 2.13 4.26 0.69 0.32
Debt-to-Capital Ratio
 0.53 0.68 0.81 0.41 0.24
Long-Term Debt-to-Capital Ratio
 0.38 0.64 0.65 0.00 0.00
Financial Leverage Ratio
 3.67 5.39 15.76 2.66 2.32
Debt Service Coverage Ratio
 1.24 6.27 -6.53 0.22 1.72
Interest Coverage Ratio
 -9.09 16.28 -111.45 15.74 80.11
Debt to Market Cap
 0.38 0.55 0.22 0.15 0.04
Interest Debt Per Share
 0.16 0.18 0.18 0.26 0.13
Net Debt to EBITDA
 -45.15 1.04 -0.49 4.86 0.40
Profitability Margins
Gross Profit Margin
58.30%63.62%27.95%90.58%23.94%
EBIT Margin
-8.25%20.84%-153.58%21.78%22.99%
EBITDA Margin
-1.00%32.93%-137.30%34.76%23.01%
Operating Profit Margin
-8.25%20.33%-157.03%29.59%20.84%
Pretax Profit Margin
17.89%19.59%-154.99%19.90%22.73%
Net Profit Margin
32.00%19.59%-154.99%10.97%18.32%
Continuous Operations Profit Margin
32.00%19.59%-154.99%10.97%18.32%
Net Income Per EBT
178.82%100.00%100.00%55.10%80.61%
EBT Per EBIT
-216.89%96.34%98.70%67.26%109.04%
Return on Assets (ROA)
17.76%13.08%-57.93%1.65%20.00%
Return on Equity (ROE)
88.62%70.45%-913.25%4.38%46.39%
Return on Capital Employed (ROCE)
-8.76%23.98%-286.33%10.44%52.72%
Return on Invested Capital (ROIC)
-7.95%21.66%-175.62%3.85%32.19%
Return on Tangible Assets
17.76%13.08%-57.93%1.65%20.00%
Earnings Yield
29.67%19.76%-68.37%1.44%6.48%
Efficiency Ratios
Receivables Turnover
 1.51 145.69 0.44 0.17 1.44
Payables Turnover
 12.15 8.58 20.24 73.85 2.42K
Inventory Turnover
 17.93 139.67 112.50 13.69 560.34
Fixed Asset Turnover
 3.78 12.97 4.01 1.55 375.69
Asset Turnover
 0.56 0.67 0.37 0.15 1.09
Working Capital Turnover Ratio
 -27.65 8.96 1.24 0.41 10.56
Cash Conversion Cycle
 232.64 -37.41 813.19 2.11K 254.83
Days of Sales Outstanding
 242.34 2.51 827.97 2.09K 254.33
Days of Inventory Outstanding
 20.36 2.61 3.24 26.67 0.65
Days of Payables Outstanding
 30.05 42.53 18.03 4.94 0.15
Operating Cycle
 262.70 5.12 831.22 2.12K 254.98
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 0.06 0.02 -0.06 -0.01
Free Cash Flow Per Share
 -0.02 0.06 0.02 -0.07 -0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.05 0.97 0.96 1.15 1.27
Dividend Paid and CapEx Coverage Ratio
 -19.92 29.19 23.13 -6.81 -3.74
Capital Expenditure Coverage Ratio
 -19.92 29.19 23.13 -6.81 -3.74
Operating Cash Flow Coverage Ratio
 -0.13 0.34 0.13 -0.25 -0.08
Operating Cash Flow to Sales Ratio
 -0.07 0.20 0.09 -0.43 -0.01
Free Cash Flow Yield
-6.95%19.68%3.85%-6.39%-0.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 3.26 5.06 -1.46 69.56 15.42
Price-to-Sales (P/S) Ratio
 1.04 0.99 2.27 7.63 2.83
Price-to-Book (P/B) Ratio
 2.12 3.56 13.36 3.05 7.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -13.92 5.08 25.98 -15.65 -208.61
Price-to-Operating Cash Flow Ratio
 -14.62 4.91 24.85 -17.95 -264.46
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.04 <0.01 -0.76 -0.14
Price-to-Fair Value
 2.12 3.56 13.36 3.05 7.15
Enterprise Value Multiple
 -149.47 4.05 -2.14 26.80 12.67
Enterprise Value
 133.83M 120.81M 204.38M 386.99M 825.10M
EV to EBITDA
 -152.94 4.05 -2.14 26.80 12.67
EV to Sales
 1.53 1.33 2.94 9.32 2.92
EV to Free Cash Flow
 -20.40 6.83 33.70 -19.12 -215.37
EV to Operating Cash Flow
 -21.43 6.60 32.25 -21.92 -273.03
Tangible Book Value Per Share
 0.14 0.08 0.04 0.36 0.39
Shareholders’ Equity Per Share
 0.14 0.08 0.04 0.36 0.39
Tax and Other Ratios
Effective Tax Rate
 -0.79 0.00 0.00 0.45 0.19
Revenue Per Share
 0.29 0.30 0.24 0.15 0.99
Net Income Per Share
 0.09 0.06 -0.38 0.02 0.18
Tax Burden
 1.79 1.00 1.00 0.55 0.81
Interest Burden
 -2.17 0.94 1.01 0.91 0.99
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.67 0.57 0.56 0.53 0.15
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 -1.23 1.03 -0.06 -2.14 -0.12
Currency in HKD